High-dose chemotherapy sensitizes locally advanced esophageal squamous cell carcinoma to PD-1 blockade for a higher pathological complete response rate and survival

Background: PD-1 inhibitor and chemotherapy demonstrated durable antitumor activity with a manageable safety profile as the first-line treatment in patients with advanced esophageal squamous cell carcinoma (ESCC). The present study aimed to evaluate the efficacy of PD-1 inhibitors plus different dos...

詳細記述

書誌詳細

出版年:	Translational Oncology
主要な著者:	Peiyuan Wang, Mengxia Lei, Guibin Weng, Rongfang Huang, Hui Lin, Wenwei Wei, Yujie Chen, Hao He, Peng Chen, Derong Zhang, Weijie Chen, Hang Zhou, Pengqiang Gao, Shuoyan Liu, Feng Wang
フォーマット:	論文
言語:	英語
出版事項:	Elsevier 2023-10-01
主題:	Locally advanced esophageal squamous cell carcinoma Neoadjuvant chemotherapy PD-1 inhibitor Dose intensity Efficacy
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S1936523323001225